Now available as directly compressible grades, METHOCEL™ DC2 polymers deliver exceptional flow properties and process capability as well as consistent modified release performance for matrix formulations. METHOCEL DC2 will enable manufacturers to replace costly wet granulation in matrix tablet production with cost effective dry granulation and direct compression techniques.
METHOCEL DC2 helps you enjoy the benefits of dry powder processing techniques:
- lower manufacturing costs by up to 60%
- results in more reproducible and robust tablet properties
- better formulation option for heat and moisture-sensitive APIs
- no additives, means no regulatory hurdles, as METHOCEL DC2 is pure HPMC
Three direct compression grades of METHOCEL DC2 are now available: K100 LV, K4M and K100M; chemically identical to current METHOCEL Premium products and meet USP, PhEur and JPE specifications.
Colorcon, through the Controlled Release Alliance, has exclusive, global sales and distribution rights for METHOCEL products from Dow Pharma & Food Solutions for use in controlled release applications.